Filter
2044
Filtered Results: 2044
Text search:
pharmaceutical
management
Featured
Recommendations
197
New Publications
571
Language
Document type
No document type
1053
Studies & Reports
373
Guidelines
345
Manuals
94
Strategic & Response Plan
92
Fact sheets
32
Training Material
24
Situation Updates
12
Resource Platforms
11
Infographics
4
Brochures
3
Online Courses
1
Countries / Regions
Kenya
87
Ethiopia
81
India
81
Global
75
South Africa
54
Nigeria
46
Western and Central Europe
46
Sierra Leone
40
Liberia
40
Uganda
38
Ghana
32
Nepal
30
Rwanda
30
Tanzania
29
Namibia
29
Zambia
28
Malawi
26
Africa
25
Bangladesh
25
Ukraine
22
Latin America and the Carribbean
22
Philippines
20
Indonesia
18
Syria
17
Eastern Europe
17
Lesotho
16
Zimbabwe
15
Cambodia
15
South–East Asia Region
13
Myanmar / Burma
13
Eswatini/ Swaziland
13
Congo, Democratic Republic of
12
Botswana
11
West and Central Africa
10
Germany
9
Eastern Europe and Central Asia
9
Cameroon
8
Asia
8
Russia
8
South Sudan
8
Senegal
7
Guinea
7
East and Southern Africa
7
Brazil
7
Thailand
6
Burkina Faso
6
Haiti
6
Western Pacific Region
5
Benin
4
China
4
Albania
4
Laos
4
Mozambique
4
Middle East and North Africa
4
Vietnam
4
Papua New Guinea
4
Pakistan
4
North Macedonia
3
Chile
3
Fiji
3
Afghanistan
3
USA
3
Jordan
3
United Kingdom
3
Egypt
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Kyrgyzstan
2
Lithuania
2
North America
2
Jamaica
2
Lebanon
2
Moldova
2
Yemen
2
Georgia
2
Central African Republic
2
Iraq
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Peru
1
Bulgaria
1
Armenia
1
Venezuela
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Sri Lanka
1
Romania
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
858
Clinical Guidelines
137
Public Health
107
Key Resources
103
Women & Child Health
50
Pharmacy & Technologies
32
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
Pharmacy
202
AMR
192
COVID-19
149
Mental Health
105
HIV
101
TB
101
NTDs
65
Rapid Response
61
NCDs
47
Planetary Health
46
Caregiver
42
Ebola & Marburg
36
Conflict
35
Global Health Education
34
Health Financing Toolbox
26
Specific Hazards
14
Refugee
11
Natural Hazards
11
Disability
11
Polio
11
Social Ethics
3
Cholera
2
South Sudan
1
Zika
1
Some of the key findings of the report include:
Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia
35% of carers across the world said that they have hidden the diagnosis of de...
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
Biodiversity and healthy natural ecosystems, including protected areas in and around cities, provide ecosystem benefits and services that support human health, including reducing flood risk, filtering air pollutants, and providing a reliable supply of clean drinking water. These services help to red...
Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK.
'Health and human rights in the new world (dis)order' outlines a shifting rights landscape in which new ...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Transforming the Quality of Health Care in Ethiopia
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
16.7.2021
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are ...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
